No Data
Celularity's Strategic Partner Announces Groundbreaking For Stem Cell & Regenerative Medicine Center In Asia Pacific
Celularity Shares Are Trading Higher. The Nasdaq Listing Qualifications Hearings Panel Has Cancelled the Previously Scheduled Hearing Regarding the Company's Non-compliance.
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
Sector Update: Health Care Stocks Rise Late Afternoon
Celularity CELU Increased Sales Guidance; Ensysce ENSC NASDAQ Extension
Top Midday Gainers
No Data
No Data